As a recent newcomer to this forum, I can only say, there's equal responsibility on all holders to own their decisions. The advice to DYOR really does mean something. If biases and generalisations are thrown around in the throes of trading speculation/analysis, then so be it. That's the nature of high-risk psychology involved in all this. It's good for others to point these out, of course. But it's ultimately up to holders to use their own cognitive filters and research to arrive at their own informed decisions with conviction. Otherwise they shouldn't be here at all.
Speaking for myself, I'm too focused on the fundamentals to take too much notice of the charting - the key fundamental being (for me at least) management and BOD competence to get Viraleze well and truly out there on the market. Any trading decisions to buy dips will amount to little if we don't actually sell enough of the bloody thing!
- Forums
- ASX - By Stock
- SPL
- Are the vaccines safe. Denmark, Norway and Iceland suspend AstraZeneca COVID shots after blood clot
Are the vaccines safe. Denmark, Norway and Iceland suspend AstraZeneca COVID shots after blood clot, page-67
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.003(3.19%) |
Mkt cap ! $39.72M |
Open | High | Low | Value | Volume |
9.5¢ | 10.0¢ | 9.5¢ | $190.9K | 1.972M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 830101 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 89991 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 830101 | 0.095 |
1 | 61400 | 0.092 |
2 | 300000 | 0.091 |
2 | 311111 | 0.090 |
1 | 400000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 89991 | 3 |
0.105 | 149684 | 5 |
0.110 | 202467 | 5 |
0.115 | 103392 | 3 |
0.120 | 150305 | 10 |
Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |